Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 4Ovarian Neoplasms 2Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Small Cell Lung Carcinoma 1Neoplasms 1Metastatic Pancreatic Adenocarcinoma 1Metastatic Adenocarcinoma of the Pancreas 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Head and Neck Neoplasms 1Glioblastoma 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Biliary Tract Neoplasms 1Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 2irinotecan sucrosofate 1cabiralizumab 1Oxaliplatin 1Nivolumab 1Leucovorin 1Irinotecan 1IMM-101 1Fluorouracil 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced Pancreatic Cancer × irinotecan sucrosofate × Clear all
NCT03336216 2024-07-23

A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

Bristol-Myers Squibb

Phase 2 Completed
205 enrolled 30 charts
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡